维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="TOPALY J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia显示文摘	PERZ J TOPALY J FRUEHAUF S	2002	Leuk Lymphoma2002，43，1：	1
2	Combination therapy with imatinib mesylate (ST1571): synopsis of in vitrostudies 显示文摘	Topaly J Zeller WJ Fruehauf S	2002	Br J Haematol2002，119，：	1
3	Development and optimization of a real- time quantitative PCR-based method for the titration of AAV-2vector stocks显示文摘	VELDVIJK M R TOPALY J LAUFS S	2002	Mol Ther2002，6，2：	1
4	MIRO and IRbase: IT tools for the epidemiological monitoring of insecticide resistance in mosqui- to disease vectors显示文摘	Dialynas E Topalis P Vontas J	2009	PLoS Negl Trop Dis2009，3，6：	1
5	Combination treatment of imatinib-sensitive and-resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors显示文摘	Radujkovic A Topaly J Fruehauf S	2006	Anticancer Res2006，26，3：	1
6	Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks显示文摘	Veldwijk M R Topaly J Laufs S	2002	Mol Ther2002，6，：	1
7	Synergistic activity of the new ABL-specific tyrosine kinase inhibitor imatinib and chemotherapeutic drugs on BCR/ABL positive chronic myelogenous leukemia cells 显示文摘	Topaly J Zeller WJ Fruehauf S	2001	Leukemia2001，15，：	1
8	Synergistic activity of the new ABL -specific tyrosine kinase inhibitor ST1571 and chemotherapeutic drugs on bcr-abl-positive chronic myelogenous leukemia cells显示文摘	Topaly J Zeller WJ Fruehauf S		0，，：	1
9	Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML ceils overexpress- ing BCR-ABL-inhibition of P-glycoprotein function by 17-AAG 显示文摘	Radujkovic A Schad M Topaly J	2005	Leukemia2005，19，7：	1
10	Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing Bcr-Abl-inhibition of P-glycoprotein function by 17-AAG显示文摘	Radujkovic A Schad M Topaly J	2005	Leukemia2005，19，7：	1
11	Synergistic activity of the new ABL-specific tyrosine kinase inhibitor ST1 571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells 显示文摘	Topaly J Zeller WJ Fruehauf S	2001	Leukemia2001，15，3：	1
12	Synergistic activity of the new abl-specific tyrosine kinase inhibitor ST1-571 and chemotherapeutic drugs on bcrabl-positive chronic myelogenous leukemia cells显示文摘	Topaly J Zeller W J Fruehauf S		0，，：	1
13	Synergistic activity of the new ABL-specific tyrosine inhibitor STI-571 and chemothera-peutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells显示文摘	Topaly J Zeller WJ Fruehanf S	2001	Leukemia2001，15，3：	1
14	Synergistic activity of the new abl-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on bcr-abl-positive chronic myelogenous leukemia cells显示文摘	Topaly J Zeller WJ Fruehauf S	2001	Leukemia2001，15，3：	1
15	Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective in- duction therapy for patients with chronic myeloid leukemia in myeloid blast crisis 显示文摘	FRUEHAUF S TOPALY J BUSS EC	2007	Cancer2007，109，：	1
16	Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells显示文摘	Topaly J Zeller WJ Fruehauf S	2001	Leukemia2001，15，3：	1
17	Synergistic activity of imatinib and 17-AAG in imatinib-resisitant CML cells overexpressing BCR-ABL -inhibition of P-glycoprotein function by 17-AAG显示文摘	Radujkovic A Schad M Topaly J	2005	Leukemia2005，19，7：	1
18	Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL-Inhibition of P-glycoprotein 显示文摘	Radujkovie A Schad M Topaly J	2005	Leukemia2005，19，7：	1
19	Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells显示文摘	Zeller WJ Fruehauf S	2001	Leukemia2001，15，3：	1
20	Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells显示文摘	Topaly J Zeller WJ Fruehauf S	2001	Leukemia2001，15，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示